Association of aldehyde dehydrogenase 2 genotype with prevalence of diabetic retinopathy

Yoshihiko Suzuki, Chisato Murata, Yoshito Atsumi, Kempei Matsuoka, Takayuki Asahina, Akira Shimada, Kazuhiro Hosokawa, Matsuo Taniyama, Taro Muramatsu

Research output: Contribution to journalArticle

Abstract

The influence of aldehyde dehydrogenase 2 (ALDH 2) genotype on diabetic retinopathy was investigated in 212 individuals with non-insulin dependent diabetes mellitus (NIDDM). The prevalence of proliferative retinopathy was lower [p < 0.05) in the 92 patients with inactive ALDH 2 than in the 120 patients with active ALDH2. In patients with NIDDM of less than 10 years' duration, the prevalence of proliferative retinopathy was 6.5% (4/62) in those with active ALDH 2 and 0% (0/45) in those with inactive ALDH 2. In patients with NIDDM of more than 10 years' duration, the prevalence of proliferative retinopathy was 12.1% (7/58) among those with active ALDH 2 and 4.3% (2/47) among those with inactive ALDH 2. Thus, the prevalence of proliferative retinopathy was relatively high and its onset earlier in patients with active ALDH 2 genotype compared to those with inactive ALDH 2 genotype. From these results, we suggest that ALDH 2 genotype could be a genetic marker for diabetic retinopathy, especially among those with NIDDM.

Original languageEnglish
Pages (from-to)955-958
Number of pages4
JournalFolia Ophthalmologica Japonica
Volume48
Issue number8
Publication statusPublished - 1997 Aug
Externally publishedYes

Fingerprint

Aldehyde Dehydrogenase
Diabetic Retinopathy
Genotype
Type 2 Diabetes Mellitus
Genetic Markers

Keywords

  • Aldehyde Dehydrogenase
  • ALDH 2
  • Chlorpropamide Alcohol Flushing Test
  • Diabetes Mellitus
  • Diabetic Retinopathy

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Suzuki, Y., Murata, C., Atsumi, Y., Matsuoka, K., Asahina, T., Shimada, A., ... Muramatsu, T. (1997). Association of aldehyde dehydrogenase 2 genotype with prevalence of diabetic retinopathy. Folia Ophthalmologica Japonica, 48(8), 955-958.

Association of aldehyde dehydrogenase 2 genotype with prevalence of diabetic retinopathy. / Suzuki, Yoshihiko; Murata, Chisato; Atsumi, Yoshito; Matsuoka, Kempei; Asahina, Takayuki; Shimada, Akira; Hosokawa, Kazuhiro; Taniyama, Matsuo; Muramatsu, Taro.

In: Folia Ophthalmologica Japonica, Vol. 48, No. 8, 08.1997, p. 955-958.

Research output: Contribution to journalArticle

Suzuki, Y, Murata, C, Atsumi, Y, Matsuoka, K, Asahina, T, Shimada, A, Hosokawa, K, Taniyama, M & Muramatsu, T 1997, 'Association of aldehyde dehydrogenase 2 genotype with prevalence of diabetic retinopathy', Folia Ophthalmologica Japonica, vol. 48, no. 8, pp. 955-958.
Suzuki Y, Murata C, Atsumi Y, Matsuoka K, Asahina T, Shimada A et al. Association of aldehyde dehydrogenase 2 genotype with prevalence of diabetic retinopathy. Folia Ophthalmologica Japonica. 1997 Aug;48(8):955-958.
Suzuki, Yoshihiko ; Murata, Chisato ; Atsumi, Yoshito ; Matsuoka, Kempei ; Asahina, Takayuki ; Shimada, Akira ; Hosokawa, Kazuhiro ; Taniyama, Matsuo ; Muramatsu, Taro. / Association of aldehyde dehydrogenase 2 genotype with prevalence of diabetic retinopathy. In: Folia Ophthalmologica Japonica. 1997 ; Vol. 48, No. 8. pp. 955-958.
@article{feaf903ef642496b8eab33ad78266665,
title = "Association of aldehyde dehydrogenase 2 genotype with prevalence of diabetic retinopathy",
abstract = "The influence of aldehyde dehydrogenase 2 (ALDH 2) genotype on diabetic retinopathy was investigated in 212 individuals with non-insulin dependent diabetes mellitus (NIDDM). The prevalence of proliferative retinopathy was lower [p < 0.05) in the 92 patients with inactive ALDH 2 than in the 120 patients with active ALDH2. In patients with NIDDM of less than 10 years' duration, the prevalence of proliferative retinopathy was 6.5{\%} (4/62) in those with active ALDH 2 and 0{\%} (0/45) in those with inactive ALDH 2. In patients with NIDDM of more than 10 years' duration, the prevalence of proliferative retinopathy was 12.1{\%} (7/58) among those with active ALDH 2 and 4.3{\%} (2/47) among those with inactive ALDH 2. Thus, the prevalence of proliferative retinopathy was relatively high and its onset earlier in patients with active ALDH 2 genotype compared to those with inactive ALDH 2 genotype. From these results, we suggest that ALDH 2 genotype could be a genetic marker for diabetic retinopathy, especially among those with NIDDM.",
keywords = "Aldehyde Dehydrogenase, ALDH 2, Chlorpropamide Alcohol Flushing Test, Diabetes Mellitus, Diabetic Retinopathy",
author = "Yoshihiko Suzuki and Chisato Murata and Yoshito Atsumi and Kempei Matsuoka and Takayuki Asahina and Akira Shimada and Kazuhiro Hosokawa and Matsuo Taniyama and Taro Muramatsu",
year = "1997",
month = "8",
language = "English",
volume = "48",
pages = "955--958",
journal = "Folia Ophthalmologica Japonica",
issn = "0015-5667",
publisher = "Nihon Ganka Kiyokai",
number = "8",

}

TY - JOUR

T1 - Association of aldehyde dehydrogenase 2 genotype with prevalence of diabetic retinopathy

AU - Suzuki, Yoshihiko

AU - Murata, Chisato

AU - Atsumi, Yoshito

AU - Matsuoka, Kempei

AU - Asahina, Takayuki

AU - Shimada, Akira

AU - Hosokawa, Kazuhiro

AU - Taniyama, Matsuo

AU - Muramatsu, Taro

PY - 1997/8

Y1 - 1997/8

N2 - The influence of aldehyde dehydrogenase 2 (ALDH 2) genotype on diabetic retinopathy was investigated in 212 individuals with non-insulin dependent diabetes mellitus (NIDDM). The prevalence of proliferative retinopathy was lower [p < 0.05) in the 92 patients with inactive ALDH 2 than in the 120 patients with active ALDH2. In patients with NIDDM of less than 10 years' duration, the prevalence of proliferative retinopathy was 6.5% (4/62) in those with active ALDH 2 and 0% (0/45) in those with inactive ALDH 2. In patients with NIDDM of more than 10 years' duration, the prevalence of proliferative retinopathy was 12.1% (7/58) among those with active ALDH 2 and 4.3% (2/47) among those with inactive ALDH 2. Thus, the prevalence of proliferative retinopathy was relatively high and its onset earlier in patients with active ALDH 2 genotype compared to those with inactive ALDH 2 genotype. From these results, we suggest that ALDH 2 genotype could be a genetic marker for diabetic retinopathy, especially among those with NIDDM.

AB - The influence of aldehyde dehydrogenase 2 (ALDH 2) genotype on diabetic retinopathy was investigated in 212 individuals with non-insulin dependent diabetes mellitus (NIDDM). The prevalence of proliferative retinopathy was lower [p < 0.05) in the 92 patients with inactive ALDH 2 than in the 120 patients with active ALDH2. In patients with NIDDM of less than 10 years' duration, the prevalence of proliferative retinopathy was 6.5% (4/62) in those with active ALDH 2 and 0% (0/45) in those with inactive ALDH 2. In patients with NIDDM of more than 10 years' duration, the prevalence of proliferative retinopathy was 12.1% (7/58) among those with active ALDH 2 and 4.3% (2/47) among those with inactive ALDH 2. Thus, the prevalence of proliferative retinopathy was relatively high and its onset earlier in patients with active ALDH 2 genotype compared to those with inactive ALDH 2 genotype. From these results, we suggest that ALDH 2 genotype could be a genetic marker for diabetic retinopathy, especially among those with NIDDM.

KW - Aldehyde Dehydrogenase

KW - ALDH 2

KW - Chlorpropamide Alcohol Flushing Test

KW - Diabetes Mellitus

KW - Diabetic Retinopathy

UR - http://www.scopus.com/inward/record.url?scp=0030667563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030667563&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030667563

VL - 48

SP - 955

EP - 958

JO - Folia Ophthalmologica Japonica

JF - Folia Ophthalmologica Japonica

SN - 0015-5667

IS - 8

ER -